← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 1, 2005Last known activity
Jan 30, 2026
Timeline
1990s
- Jan 1, 1996
Philogen S.p.A.— Founded
Drugs by trial phase (22 distinct, 43 trials)
Phase 3 (5 own, 0 via acquisition)
Phase 2 (11 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Indications
Studied for
- Arthritis
- Arthritis, Rheumatoid
- Basal Cell Carcinoma
- Brain Neoplasms
- Breast Neoplasms
- Carcinoma
- Carcinoma, Merkel Cell
- Carcinoma, Non-Small-Cell Lung
- Colorectal Neoplasms
- Glioblastoma
- Glioma
- Leukemia, Myeloid, Acute
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Large B-Cell, Diffuse
- Melanoma
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Second Primary
- Pancreatic Neoplasms
- Recurrence
- Sarcoma
- Skin Neoplasms
Recent trials (43)
- NCT07120984Lead sponsorPhase 2Jan 30, 2026
- NCT07228442Lead sponsorPhase 2Dec 31, 2025
- NCT07245992Lead sponsorPhase 1Dec 31, 2025
- NCT07227870Lead sponsorPhase 2Dec 31, 2025
- NCT06840548Lead sponsorPhase 1Apr 16, 2025
- NCT06840535Lead sponsorPhase 1Apr 8, 2025
- NCT06336291Lead sponsorPhase 2Jun 30, 2024
- NCT05784597Lead sponsorPhase 1Apr 27, 2023
- NCT05622175Lead sponsorPhase 1Mar 31, 2023
- NCT05329792Lead sponsorPhase 2Jul 1, 2022
- NCT05304663Lead sponsorPhase 1Jun 1, 2022
- NCT04443010Lead sponsorPhase 1/Phase 2Dec 31, 2020
- NCT04573192Lead sponsorPhase 1/Phase 2Nov 30, 2020
- NCT04733183Lead sponsorPhase 2Aug 28, 2020
- NCT04471987Lead sponsorPhase 1Jul 1, 2020
Details
- Founded
- Sovicille, IT Jan 1, 1996
- Last known activity
- Jan 30, 2026